Ovarian cancer screening: potential effect on mortality.

Area of Science:

• Oncology
• Preventive Medicine
• Medical Diagnostics

Background:

• Ovarian cancer poses a significant health challenge with often late-stage diagnosis.
• Current screening methods for ovarian cancer lack sufficient sensitivity and specificity.
• Serum tumor markers and ultrasonography are under investigation as potential screening tools.

Purpose of the Study:

• To estimate the potential impact of ovarian cancer screening tests on mortality.
• To evaluate the effectiveness of screening based on varying test sensitivities.
• To project the number of additional survivors from a hypothetical universal screening program.

Main Methods:

• Utilized US data on ovarian cancer incidence and survival rates.
• Modeled the effect of screening tests with different sensitivity levels on mortality.
• Calculated potential benefits under optimistic assumptions of screening uptake and case management.

Main Results:

• An 80% sensitive screening test could reduce ovarian cancer mortality by up to 50% under ideal conditions.
• Screening benefits are most pronounced for women aged 45 and older.
• High specificity (over 98%) is crucial to limit false-positive results (at least 50 per true positive).
• Universal screening of women aged 45-74 could yield approximately 5000 additional 5-year survivors annually.
• Actual program impact is likely lower due to suboptimal screening uptake.

Conclusions:

• Ovarian cancer screening holds promise for reducing mortality, particularly with sensitive tests.
• Optimizing test specificity is critical to balance benefits against false positives.
• Widespread adoption and effective management of detected cases are essential for realizing screening's full potential.
• The projected benefits are contingent on achieving high screening participation rates.